Phase 2 trial of erlotinib with or without PF-3512676 (CPG 7909, a Toll-like receptor 9 agonist) in patients with advanced recurrent EGFR-positive non-small cell lung cancer. (Q37092663)
Jump to navigation
Jump to search
scientific article published on 10 May 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 2 trial of erlotinib with or without PF-3512676 (CPG 7909, a Toll-like receptor 9 agonist) in patients with advanced recurrent EGFR-positive non-small cell lung cancer. |
scientific article published on 10 May 2013 |
Statements
Phase 2 trial of erlotinib with or without PF-3512676 (CPG 7909, a Toll-like receptor 9 agonist) in patients with advanced recurrent EGFR-positive non-small cell lung cancer (English)
John J Nemunaitis
Abraham Chachoua
Peter D Eisenberg
Luiz E Raez
J Daniel Cuevas
Cecile B Mather
Rebecca J Benner
1 reference
1 reference